Serum cytokines, interleukin-2 receptor, and soluble intercellular adhesion molecule-1 in oral disorders.
Serum levels of soluble intercellular adhesion molecule-1, soluble interleukin-2 receptor, and cytokines such as interleukin-3, interleukin-4, interleukin-6, tumor necrosis factor-alpha, and granulocyte-macrophage colony-stimulating factor were examined in patients with oral disorders with 20 healthy persons used as control subjects. Patients studied included 30 with squamous cell carcinoma, 26 with oral lichen planus, 20 with recurrent aphthous ulcer, 19 with acute odontogenic bacterial infection, 16 with pseudomembranous candidiasis, and 16 with herpetic gingivostomatitis. Compared with levels in control subjects, detectable serum levels of interleukin-3 (> or = 10 pg/ml) existed more frequently in pseudomembranous candidiasis (13/16), acute odontogenic bacterial infection (14/19), and squamous cell carcinoma (24/30) and of granulocyte-macrophage colony-stimulating factor (> or = 4 pg/ml) more frequently in recurrent aphthous ulcer (15/20) and squamous cell carcinoma (21/30). These cytokine levels were increased with T stage of squamous cell carcinoma. About 20 pg/ml of interleukin-4 was detected in serum from one third to one fourth of patients with oral lichen planus, recurrent aphthous ulcer, and squamous cell carcinoma. Tumor necrosis factor-alpha was hardly detected in most patients except those with oral lichen planus and squamous cell carcinoma in which about one third of the patients had more than 40 pg/ml of tumor necrosis factor-alpha in serum. More than 10 pg/ml of interleukin-6 was frequently detected in all disorders, especially recurrent aphthous ulcer (18/20), pseudomembranous candidiasis (12/16), and acute odontogenic bacterial infection (17/19).(ABSTRACT TRUNCATED AT 250 WORDS)
Yamamoto
T
T
Department of Oral Surgery, Kochi Medical School, Japan.
Yoneda
K
K
Ueta
E
E
Osaki
T
T
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002180:Candidiasis, Oral / Q000276:immunology; D002294:Carcinoma, Squamous Cell / Q000276:immunology; D016022:Case-Control Studies; D016009:Chi-Square Distribution; D002648:Child; D016207:Cytokines / Q000097:blood*; D018450:Disease Progression; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000097:blood; D006801:Humans; D018799:Intercellular Adhesion Molecule-1 / Q000097:blood*; D007377:Interleukin-3 / Q000097:blood; D015847:Interleukin-4 / Q000097:blood; D015850:Interleukin-6 / Q000097:blood; D017676:Lichen Planus, Oral / Q000276:immunology; D008297:Male; D008875:Middle Aged; D009059:Mouth Diseases / Q000276:immunology*; D009062:Mouth Neoplasms / Q000276:immunology*; D010508:Periodontal Abscess / Q000276:immunology; D015375:Receptors, Interleukin-2 / Q000032:analysis* / Q000037:antagonists & inhibitors; D013281:Stomatitis, Aphthous / Q000276:immunology; D013283:Stomatitis, Herpetic / Q000276:immunology; D014409:Tumor Necrosis Factor-alpha / Q000032:analysis
D016207:Cytokines; D007377:Interleukin-3; D015850:Interleukin-6; D015375:Receptors, Interleukin-2; D014409:Tumor Necrosis Factor-alpha; D018799:Intercellular Adhesion Molecule-1; D015847:Interleukin-4; D016178:Granulocyte-Macrophage Colony-Stimulating Factor